Title for MeetingAbstracts
Alphabetical listing of titles
-
One Step Further: From Outreach to Prevention Case Management for High Risk Women of Color in San Francisco.
-
One week long rock festival - PEPSI Island 2001 - as the most effective HIV prevention activity in Hungary.
-
One World Alliance for better reviews.
-
One world, one hope: the cost of making antiretroviral therapy available to all nations.
-
One year after the news: Tony's story.
-
One year experience in the first central radiopharmacy in Spain.
-
One year follow-up of a one-session AIDS prevention discussion group.
-
One year follow-up of CD4 and CD8 cytokine secreting lymphocytes in HIV infected patients treated with stavudine + didanosine + ritonavir.
-
One year follow-up of zidovudine plus acyclovir in asymptomatic HIV-seropositives.
-
One Year of HAART in Mozambique: Survival, Virological, and Immunological Results of DREAM Project in Adults and Children.
-
One year out: experiences in a PMTCT program in an urban African setting.
-
One year supplementation of HIV-positive patients with selenium or beta-carotene.
-
One-day hospital follow-up of HIV infected drug addicts: various histories, a specific support unit.
-
One-week therapy with TMC125, a next generation NNRTI, demonstrates high potency in treatment-experienced HIV-1 infected individuals with phenotypic NNRTI-resistance.
-
One-Year Evolution of Resistance Associated Mutations in the Viradapt Study.
-
One-year follow-up of CMV cellular load in AIDS patients, using viremia, pp65 antigenemia, and a new molecular test bDNA CMV 2.0.
-
One-year follow-up of HIV-infected children receiving combination therapy with indinavir, stavudine (d4T), and didanosine (ddI).
-
One-Year Outcome of Protease Inhibitors (PI)-Triple Therapy in a Cohort of Naive HIV-Infected Intravenous Drug Users on Maintenance Therapy with Methadone.
-
One-Year Outcomes among Members of a Dual-Recovery Self-Help Program.
-
One-Year Rate and Baseline Predictors of Discordant Virological-Immunological Responses in Naive Patients on HAART in the Clinical Setting.
-
One-Year Results of the Retrovirus-Activity-Comparing-Trial (RACING-TRIAL).
-
Onevillage Initiative: holistic ICT development for community prosperity.
-
Ongoing and future trials of antiretroviral therapy in the pediatric AIDS clinical trials group (PACTG).
-
Ongoing experience with nelfinavir substitution for indinavir or ritonavir/saquinavir in HIV+ suppressed below 400 copies/ml.
-
Ongoing exposure of humans to simian immunodeficiency viruses in West Central Africa poses a risk for additional zoonotic transmissions.
-
Ongoing follow-up of injecting drug users (IDUs) in the AIDSVAXB/E vaccine efficacy trial in Bangkok, Thailand.
-
Ongoing impact evaluation of the condom use promotion/desensitization program for preventing AIDS in the Dominican Republic.
-
Ongoing Surveillance for Effect of Conjugate Vaccine on Invasive Pneumococcal Disease in the U.S.
-
Ongoing therapeutic trials in France in December 1991.